title: Cognitive impairment in ICU survivors: assessment and therapy.
abstract: Cognitive impairment occurs in up to one-third of intensive care patients and may affect one or more cognitive domains. Because data are scarce on therapies for this complication, prevention remains the prevailing strategy. In this review, we discuss the clinical approach to cognitive impairment after an intensive care unit (ICU) stay.
authors.affiliation: Rehabilitation Department, Creighton University Medical Center, Omaha, NE, USA.
authors.forename: Rachel
authors.initials: R
authors.lastname: Wergin
authors.forename: Ariel
authors.initials: A
authors.lastname: Modrykamien
mesh_terms: D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003071:Cognition; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D015928:Cognitive Behavioral Therapy; D016638:Critical Illness; D000077265:Donepezil; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D007362:Intensive Care Units; D008774:Methylphenidate / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011594:Psychometrics; D017741:Survivors
chemical_list: D002800:Cholinesterase Inhibitors; D018765:Dopamine Uptake Inhibitors; D007189:Indans; D010880:Piperidines; D008774:Methylphenidate; D000077265:Donepezil